140 likes | 264 Views
"GeneScience Pharmaceuticals Co., Ltd. - Product Pipeline Review - 2014"report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications.
E N D
Category : Pharmaceuticals & Healthcare Myungmoon pharmaceutical Co.,Ltd. - Product Pipeline Review - 2014 Browse Complete Report - http://www.aarkstore.com/pharmaceuticals-healthcare/63686/myungmoon-pharmaceutical-coltd-product-pipeline-review
Myungmoon pharmaceutical Co.,Ltd. - Product Pipeline Review - 2014
Summary Global Markets Direct’s, ‘Myungmoon pharmaceutical Co.,Ltd. - Product Pipeline Review - 2014’, provides an overview of the Myungmoon pharmaceutical Co.,Ltd.’s pharmaceutical research and development focus.This report provides comprehensive information on the current therapeutic developmental pipeline of Myungmoon pharmaceutical Co.,Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. ”Myungmoon pharmaceutical Co.,Ltd. - Product Pipeline Review - 2014"report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.
Summary Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope - The report provides brief overview of Myungmoon pharmaceutical Co.,Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Myungmoon pharmaceutical Co.,Ltd.’s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Myungmoon pharmaceutical Co.,Ltd.’s pipeline products
Reasons to buy - Evaluate Myungmoon pharmaceutical Co.,Ltd.’s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Myungmoon pharmaceutical Co.,Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Myungmoon pharmaceutical Co.,Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Myungmoon pharmaceutical Co.,Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Myungmoon pharmaceutical Co.,Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Content List of Tables 3List of Figures 3Myungmoon pharmaceutical Co.,Ltd. Snapshot 4Myungmoon pharmaceutical Co., Ltd. Overview 4Key Information 4Key Facts 4Myungmoon pharmaceutical Co., Ltd. - Research and Development Overview 5Key Therapeutic Areas 5Myungmoon pharmaceutical Co., Ltd. - Pipeline Review 7Pipeline Products by Stage of Development 7Pipeline Products - Monotherapy 8Myungmoon pharmaceutical Co.,Ltd. - Pipeline Products Glance 9Myungmoon pharmaceutical Co.,Ltd. - Early Stage Pipeline Products 9Discovery Products/Combination Treatment Modalities 9
Table of Content Myungmoon pharmaceutical Co.,Ltd. - Drug Profiles 10MM-A01-01 10Product Description 10Mechanism of Action 10R&D Progress 10MM-P01-01 11Product Description 11Mechanism of Action 11R&D Progress 11MM-P01-02 12Product Description 12Mechanism of Action 12R&D Progress 12MM-P02-01 13Product Description 13Mechanism of Action 13R&D Progress 13
List Of Tables Myungmoon pharmaceutical Co.,Ltd., Key Information 4Myungmoon pharmaceutical Co.,Ltd., Key Facts 4Myungmoon pharmaceutical Co.,Ltd. - Pipeline by Indication, 2014 6Myungmoon pharmaceutical Co.,Ltd. - Pipeline by Stage of Development, 2014 7Myungmoon pharmaceutical Co.,Ltd. - Monotherapy Products in Pipeline, 2014 8Myungmoon pharmaceutical Co.,Ltd. - Discovery, 2014 9Myungmoon pharmaceutical Co.,Ltd. - Pipeline by Target, 2014 14Myungmoon pharmaceutical Co.,Ltd. - Pipeline by Molecule Type, 2014 15Myungmoon pharmaceutical Co.,Ltd. - Pipeline Products by Mechanism of Action, 2014 16Myungmoon pharmaceutical Co.,Ltd., Other Locations 17
List of Figures Myungmoon pharmaceutical Co.,Ltd. - Pipeline by Top 10 Indication, 2014 6
Related Reports • Global Neurosurgery Market 2015-2019 • Active Pharmaceutical Ingredients (API) Market in India 2015-2019 • BrainStorm Cell Therapeutics Inc. (BCLI) - Financial and Strategic SWOT Analysis Review • Ampio Pharmaceuticals, Inc. (AMPE) - Financial and Strategic SWOT Analysis Review • MiMedx Group, Inc (MDXG) - Financial and Strategic SWOT Analysis Review
Related Reports • Threshold Pharmaceuticals, Inc. (THLD) - Financial and Strategic SWOT Analysis Review • MEI Pharma, Inc. (MEIP) - Financial and Strategic SWOT Analysis Review • Titan Pharmaceuticals, Inc. (TTNP) - Financial and Strategic SWOT Analysis Review • RedHill Biopharma Ltd. (RDHL) - Financial and Strategic SWOT Analysis Review • Pharmaceuticals & Healthcare Market Research Reports
Myungmoon pharmaceutical Co.,Ltd. - Product Pipeline Review - 2014 Published: Oct 2014 | 19 Pages “Myungmoon pharmaceutical Co.,Ltd. - Product Pipeline Review - 2014”report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Price
Contact Us Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news